Explore upcoming innovations for the NovaSeq X Series

As sequencing demands scale up, the pressure to increase throughput, reduce turnaround times, and lower costs only grows. The NovaSeq X Series roadmap answers that directly — join Illumina's experts for an inside look at what's coming and when.

Looking ahead, the platform will expand accuracy capabilities to support high-confidence variant detection across demanding genomics and oncology research applications, alongside greater sequencing output and faster WGS run times for larger and more complex studies.

These build on advancements already here: new flow cell options for mid-range batching and longer read applications, high-throughput run modes designed to improve sequencing economics, and staggered starts that allow a second flow cell to load asynchronously, optimizing scheduling and maximizing system productivity.

Whether you're a current NovaSeq X user planning for future capacity or evaluating your lab's sequencing infrastructure, this session provides the forward-looking context to make informed decisions. Bring your questions directly to the Illumina team building the platform's future.

As an attendee, you will:

• Explore upcoming NovaSeq X Series innovations designed to improve output, workflow flexibility, and data quality.  
• Learn how new platform capabilities may help labs improve productivity, scheduling flexibility, and sequencing economics.
• Understand how future accuracy improvements can support demanding genomics, multiomics, and oncology research applications.
• Interact with Illumina product managers and ask questions about the NovaSeq X innovation roadmap.

Speakers

Benton Davies
Associate Director, Product Management
Illumina

Graham Bloom
Senior Product Manager
Illumina

Scott D. Hanton, PhD
Editorial Director
LabX Media Group